Detalhe da pesquisa
1.
Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study.
Ann Oncol
; 24(1): 152-60, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22967994
2.
Anemia in patients with midgut carcinoid, treated with alpha interferon: effects by erythropoietin treatment on the perceived quality of life.
Eur J Cancer Care (Engl)
; 17(2): 200-4, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18302658
3.
Regulation of insulin and glucagon secretion from rat pancreatic islets in vitro by somatostatin analogues.
Regul Pept
; 138(1): 1-9, 2007 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-16935361
4.
Determination of somatostatin receptor subtype 2 in carcinoid tumors by immunohistochemical investigation with somatostatin receptor subtype 2 antibodies.
Cancer Res
; 58(11): 2375-8, 1998 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-9622077
5.
A comparison between the efficacy of somatostatin receptor scintigraphy and that of in situ hybridization for somatostatin receptor subtype 2 messenger RNA to predict therapeutic outcome in carcinoid patients.
Cancer Res
; 56(11): 2561-5, 1996 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-8653698
6.
Somatostatin receptor scintigraphy in patients with carcinoid tumors: comparison between radioligand uptake and tumor markers.
Cancer Res
; 55(23 Suppl): 5801s-5804s, 1995 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-7493349
7.
Expression of somatostatin receptor subtypes 1-5 in pancreatic islets of normoglycaemic and diabetic NOD mice.
Eur J Endocrinol
; 153(3): 445-54, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16131608
8.
Novel long-acting somatostatin analog with endocrine selectivity: potent suppression of growth hormone but not of insulin.
Endocrinology
; 142(1): 477-86, 2001 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11145612
9.
Somatostatin receptor ligands and their use in the treatment of endocrine disorders.
Curr Pharm Des
; 5(9): 693-705, 1999 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-10495360
10.
Expression of p68 protein kinase and its prognostic significance during IFN-alpha therapy in patients with carcinoid tumours.
Eur J Cancer
; 34(13): 2046-52, 1998 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-10070309
11.
Nuclear localization of 111In after intravenous injection of [111In-DTPA-D-Phe1]-octreotide in patients with neuroendocrine tumors.
J Nucl Med
; 41(9): 1514-8, 2000 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-10994731
12.
A comparison between three commercial kits for chromogranin A measurements.
J Endocrinol
; 177(2): 337-41, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12740022
13.
Transmembrane protein tyrosine phosphatase IA-2 (ICA512) is expressed in human midgut carcinoids but is not detectable in normal enterochromaffin cells.
J Endocrinol
; 164(3): 315-22, 2000 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-10694371
14.
[111In-DTPA-D-Phe1]octreotide scintigraphy in patients with carcinoid tumours: the predictive value for somatostatin analogue treatment.
Eur J Endocrinol
; 131(6): 577-81, 1994 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-7804439
15.
Somatostatin receptor scintigraphy during treatment with lanreotide in patients with neuroendocrine tumors.
Nucl Med Biol
; 26(8): 877-82, 1999 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-10708300
16.
Expression of the five different somatostatin receptor subtypes in endocrine cells of the pancreas.
Appl Immunohistochem Mol Morphol
; 8(2): 126-32, 2000 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-10937060
17.
Levels of angiogenic peptides in sera from patients with carcinoid tumours during alpha-interferon treatment.
Anticancer Res
; 21(6A): 4087-90, 2001.
Artigo
em Inglês
| MEDLINE | ID: mdl-11911297
18.
Induction of MxA mRNA in patients with neuroendocrine tumors after interferon treatment. Lack of correlation with antitumor response.
Anticancer Res
; 15(5B): 2191-5, 1995.
Artigo
em Inglês
| MEDLINE | ID: mdl-8572623
19.
Treatment of malignant endocrine pancreatic tumors with a combination of alpha-interferon and somatostatin analogs.
Med Oncol
; 19(1): 35-42, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12025889
20.
The clinical use of interferons in the management of neuroendocrine gastroenteropancreatic tumors.
Ann N Y Acad Sci
; 733: 471-8, 1994 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-7978897